ZS studied numerous novel first launches and co-promote launches in the U.S. and Europe between 2011 and 2020. In this on-demand webinar, ZS Principal and first launch expert Ben Hohn, discusses key insights, benchmarks and best practices for first launches in oncology and rare diseases. This webinar breaks down our research and share extensive real-world experience gained from supporting more than 80% of biotech and pharmaceutical launches in the U.S. annually, including strategy, planning and cross-functional preparation across commercial, medical, marketing, operations and technology areas, as well as organizational build, timing and program design.


Viewers will learn:

  • Emerging pharma first launch trends in the U.S. and Europe
  • The impact on value of an exit after a solo or co-promoted first launch
  • Cross-functional program design to enable a successful first launch